APLS

NASDAQStock

Apellis Pharmaceuticals, Inc.

$18.69+0.30 (+1.63%)

52-Week Range

$16.36
$30.05

Key Stats

Market Cap

2.4B

P/E Ratio

60.29

Dividend Yield

Beta

0.29

Volume

785.7K

Avg Volume

2.0M

Performance

1M

-16.60%

3M

-25.12%

6M

-24.60%

YTD

-28.89%

1Y

-25.43%

3Y

-71.94%

5Y

-60.96%

Price Chart

ETF Exposure

APLS is held by 133 ETFs

ETFFund NameWeight
IYHiShares U.S. Healthcare ETF0.04%
VBVanguard Small-Cap ETF0.03%
VXFVanguard Extended Market ETF0.03%
ISCBiShares Morningstar Small-Cap ETF0.03%
JKJiShares Morningstar Small-Cap ETF0.03%
SMMDiShares Russell 2500 ETF0.03%
VHTVanguard Health Care ETF0.03%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.02%
IWRiShares Russell Mid-Cap ETF0.02%
IUSN.DEiShares MSCI World Small Cap UCITS ETF0.01%
REMCColumbia Research Enhanced Mid Cap ETF0.01%
WSML.LiShares MSCI World Small Cap UCITS ETF0.01%
WDSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
WOSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
WSMLiShares MSCI World Small-Cap ETF0.01%
ZPRS.DEState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.01%
GGUSGoldman Sachs MarketBeta Russell 1000 Growth Equity ETF0.01%
CUS1.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
CUSS.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
SXRG.DEiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
VONGVanguard Russell 1000 Growth ETF0.01%
DCORDimensional - US Core Equity 1 ETF0.01%
IWFiShares Russell 1000 Growth ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
CBUG.DEiShares $ Treasury Bond 3-7yr UCITS ETF0.01%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
ESGVVanguard ESG U.S. Stock ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
VONEVanguard Russell 1000 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWBiShares Russell 1000 ETF0.00%
IWViShares Russell 3000 ETF0.00%
RECSColumbia Research Enhanced Core ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
SPTMState Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ETFSP500.WAAmundi Core S&P 500 Swap UCITS ETF EUR Dist0.00%
LSPU.LAmundi Core S&P 500 Swap UCITS ETF USD Dist0.00%
LYP2.DEAmundi Core S&P 500 Swap UCITS ETF EUR Hedged Dist0.00%
LYPS.DEAmundi Core S&P 500 Swap UCITS ETF EUR Dist0.00%
SP5C.LAmundi Core S&P 500 Swap UCITS ETF Acc0.00%
SP5H.PAAmundi Core S&P 500 Swap UCITS ETF EUR Hedged Dist0.00%
SP5L.LAmundi Core S&P 500 Swap UCITS ETF Acc0.00%
PreviousPage 2 of 3Next

About APLS ETF Exposure

Apellis Pharmaceuticals, Inc. (APLS) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, APLS is a widely held institutional stock. The stock currently trades at $18.69. Investors can gain exposure to APLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold APLS, sorted by portfolio weight.